Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 3,564 | 164 | 258 | 2 | 0 |
| Gross Profit | 3,564 | 164 | 258 | 2 | N/A |
| Operating Expenses | 5,997 | 6,578 | 7,935 | 4,082 | 4,450 |
| Operating Income | -2,433 | -6,415 | -7,677 | -4,080 | -4,450 |
| Other Income | 317 | 320 | 370 | 444 | 429 |
| Pre-tax Income | -2,116 | -6,095 | -7,307 | -3,636 | -4,021 |
| Net Income Continuous | -2,116 | -6,095 | -7,307 | -2,916 | -4,021 |
| Net Income | $-2,116 | $-6,095 | $-7,307 | $-2,916 | $-4,021 |
| EPS Basic Total Ops | -0.13 | -0.36 | -0.44 | -0.18 | -0.26 |
| EPS Basic Continuous Ops | -0.13 | -0.36 | -0.44 | -0.17 | -0.26 |
| EPS Diluted Total Ops | -0.13 | -0.36 | -0.44 | -0.18 | -0.26 |
| EPS Diluted Continuous Ops | -0.13 | -0.36 | -0.44 | -0.17 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.36 | -0.44 | -0.18 | -0.26 |
| EBITDA(a) | $-2,426 | $-6,408 | $-7,670 | $-4,074 | $-4,443 |